{"id":"https://openalex.org/W4407833932","doi":"https://doi.org/10.3233/978-1-61499-830-3-1200","title":"The Impact of Censoring Drug Switching in Medication Adherence Measures of Chronic Single Ingredient Oral Drugs","display_name":"The Impact of Censoring Drug Switching in Medication Adherence Measures of Chronic Single Ingredient Oral Drugs","publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W4407833932","doi":"https://doi.org/10.3233/978-1-61499-830-3-1200"},"language":"en","primary_location":{"id":"doi:10.3233/978-1-61499-830-3-1200","is_oa":false,"landing_page_url":"https://doi.org/10.3233/978-1-61499-830-3-1200","pdf_url":null,"source":{"id":"https://openalex.org/S4210179765","display_name":"Studies in health technology and informatics","issn_l":"0926-9630","issn":["0926-9630","1879-8365"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Studies in Health Technology and Informatics","raw_type":"book-chapter"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103107858","display_name":"Jin Zhu","orcid":"https://orcid.org/0000-0001-9245-1885"},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhu Vivienne J.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116374567","display_name":"Overhage J. Marc","orcid":null},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Overhage J. Marc","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100348018","display_name":"Qianli Ma","orcid":"https://orcid.org/0000-0003-4504-1933"},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ma Qianli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109034813","display_name":"R. B.","orcid":null},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan Patrick B.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.85541018,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9973999857902527,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9973999857902527,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9923999905586243,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9854999780654907,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug","display_name":"Drug","score":0.7042437791824341},{"id":"https://openalex.org/keywords/censoring","display_name":"Censoring (clinical trials)","score":0.5898056626319885},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.5205051302909851},{"id":"https://openalex.org/keywords/ingredient","display_name":"Ingredient","score":0.4628331959247589},{"id":"https://openalex.org/keywords/pharmacology","display_name":"Pharmacology","score":0.42600324749946594}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7042437791824341},{"id":"https://openalex.org/C137668524","wikidata":"https://www.wikidata.org/wiki/Q189813","display_name":"Censoring (clinical trials)","level":2,"score":0.5898056626319885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5205051302909851},{"id":"https://openalex.org/C2780589914","wikidata":"https://www.wikidata.org/wiki/Q10675206","display_name":"Ingredient","level":2,"score":0.4628331959247589},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42600324749946594},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3233/978-1-61499-830-3-1200","is_oa":false,"landing_page_url":"https://doi.org/10.3233/978-1-61499-830-3-1200","pdf_url":null,"source":{"id":"https://openalex.org/S4210179765","display_name":"Studies in health technology and informatics","issn_l":"0926-9630","issn":["0926-9630","1879-8365"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Studies in Health Technology and Informatics","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W1489783725"],"abstract_inverted_index":{"We":[0],"explored":[1],"how":[2],"drug":[3,50],"switching":[4,51],"impacts":[5],"adherence":[6],"measures":[7],"for":[8,38,103,108,114,127,132,138],"common":[9],"chronic":[10],"oral":[11],"medications.":[12],"Switching":[13],"between":[14,45,146],"ingredients":[15],"with":[16,92],"the":[17,54,69,78,117],"same":[18],"indication":[19],"was":[20,41],"detected":[21],"within":[22,88],"a":[23],"30-day":[24],"grace":[25],"period.":[26],"The":[27],"proportion":[28],"of":[29,56,119],"days":[30],"covered":[31],"(PDC)":[32],"and":[33,43,59,73,110,134,141,148],"adherent":[34,120],"status":[35],"(cutoff":[36],"0.8)":[37],"each":[39],"ingredient":[40],"calculated":[42],"compared":[44],"different":[46],"censoring":[47,49,53],"approaches:":[48],"(PDCswitch),":[52],"end":[55],"dispensing":[57],"(PDCend),":[58],"fixed":[60],"365-day":[61],"period":[62],"(PDC365).":[63],"Overall,":[64],"854,380":[65],"(15.9%)":[66],"patients":[67,76,121],"in":[68,77,94],"Optum":[70],"ClinFormatics":[71],"(Optum)":[72],"150,785":[74],"(22.0%)":[75],"MarketScan":[79],"Multi-state":[80],"Medicaid":[81],"(MDCD)":[82],"had":[83],"at":[84],"least":[85],"one":[86,89],"switch":[87],"year.":[90],"Compared":[91],"PDC365":[93],"Optum,":[95],"PDCswitch":[96,147],"means":[97],"were":[98,122,144],"higher:":[99,123],"0.85":[100],"vs.":[101,106,112,125,130,136],"0.41":[102],"antihypertensive,":[104,128],"0.82":[105],"0.46":[107],"antihyperglycemics,":[109,133],"0.84":[111],"0.33":[113],"antihyerlipidemia.":[115,139],"Further,":[116],"percentages":[118],"95.8%":[124],"17.9%":[126],"85.5%":[129],"18.9%":[131],"72.1%":[135],"5.3%":[137],"Significant":[140],"modest":[142],"changes":[143],"observed":[145],"PDCend.":[149]},"counts_by_year":[],"updated_date":"2026-05-21T06:26:12.895304","created_date":"2025-10-10T00:00:00"}